The cyber threat analysis software developer has revealed $12m in series A funding, with the round being co-led by Dell Technologies Capital.

Mitoconix is exploiting research into neurodegenerative disorders undertaken by professor Daria Mochly-Rosen and her team at Stanford University.

Oncology drug developer Vivace Therapeutics revealed a $15m series A round and a $25m series B, both backed by WuXi Healthcare Ventures, as it emerged from stealth.

Johnson & Johnson and Mayo Clinic both invested in DayTwo, the developer of a microbiome health management app, with the latter set to expand its research partnership with the startup.

Sentiance, a spinout of Vrije Universiteit Brussel and Ghent University, has secured $5.2m in a series A round that included multi-university-backed fund Qbic.

Comdata and Innogy both invested as the customer support technology developer closed a series A round that will fund market penetration and technology enhancement.

Legend Capital has led a series A round for publishing-focused media company Dook Book that reportedly valued it at approximately $295m.

American Express Ventures has added $6m to the $29m Next had already raised for a series A round backed by Munich Re, Markel and Nationwide Mutual.